CARE Ratings Ltd
CARE Ratings Ltd (CARERATING) last traded at ₹1,619, a market capitalisation of ₹4,871 crore, on a P/E of 27.4. Over the past 52 weeks the stock has ranged between ₹1,393 and ₹1,838. CARE Ratings Ltd last reported results for the quarter ended Jun 2026, with sales of ₹112 crore and net profit of ₹33 crore. The next scheduled event is an analyst meet on 26 Aug 2026. Figures are as of 25 Aug 2026 and are not real time.
CARE Ratings Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
CARE Ratings Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹112 cr, up 19.1% from ₹94 cr a year earlier. Net profit was ₹33 cr, up 26.9% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 117 | 96 | 110 | 94 | 136 | 112 | 131 | 112 |
| Expenses | 62 | 66 | 62 | 66 | 68 | 72 | 70 | 77 |
| Operating profit | 56 | 30 | 47 | 28 | 68 | 40 | 61 | 35 |
| OPM % | 47% | 32% | 43% | 30% | 50% | 36% | 46% | 31% |
| Other income | 12 | 12 | 15 | 14 | 13 | 13 | 16 | 15 |
| Interest | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| Profit before tax | 64 | 39 | 59 | 37 | 77 | 49 | 72 | 45 |
| Tax % | 27% | 27% | 26% | 29% | 26% | 25% | 26% | 27% |
| Net profit | 47 | 28 | 43 | 26 | 57 | 37 | 53 | 33 |
| EPS (₹) | 15.41 | 9.29 | 14.24 | 8.61 | 18.89 | 11.96 | 17.58 | 10.73 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
CARE Ratings Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 248 | 248 | 279 | 332 | 402 | 473 | 491 |
| Operating profit | 96 | 80 | 99 | 112 | 155 | 197 | 204 |
| OPM % | 39% | 32% | 36% | 34% | 39% | 42% | 42% |
| Net profit | 91 | 77 | 85 | 103 | 140 | 174 | 180 |
| EPS (₹) | 30.39 | 25.34 | 28.12 | 33.67 | 45.85 | 56.97 | 59.16 |
TTM is the trailing twelve months to the most recent quarter.
CARE Ratings Ltd growth and returns
- 10 Years
- 5%
- 5 Years
- 14%
- 3 Years
- 19%
- TTM
- 18%
- 10 Years
- 4%
- 5 Years
- 14%
- 3 Years
- 27%
- TTM
- 25%
- 10 Years
- 3%
- 5 Years
- 20%
- 3 Years
- 26%
- 1 Year
- 1%
- 10 Years
- 19%
- 5 Years
- 16%
- 3 Years
- 18%
- Last Year
- 20%
CARE Ratings Ltd shareholding pattern
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| FIIs | 24.79% | 24.75% | 23.75% | 24.62% | 23.61% | 23.00% | 23.25% | 23.41% |
| DIIs | 25.28% | 27.50% | 29.38% | 29.76% | 31.60% | 31.30% | 31.38% | 31.58% |
| Public | 49.92% | 47.74% | 46.87% | 45.61% | 44.79% | 45.70% | 45.37% | 45.01% |
| No. of shareholders | 53,602 | 52,007 | 51,395 | 61,111 | 56,931 | 59,139 | 58,978 | 58,466 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming CARE Ratings Ltd events
The next scheduled event is an analyst meet on 26 Aug 2026.
- Analyst meetRescheduling of analyst/institutional investor meeting with Oyster Rock Capital
- Analyst meetAnalyst/Institutional Investor Meet with Hill Fort Capital
- Analyst meetAnalyst/Institutional Investor Meet with TenCore Partners
See the full results calendar for every Indian company reporting in the next 30 days.
CARE Ratings Ltd corporate filings
- Intimation of Reschedule of Investor MeetCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has issued an intimation regarding the rescheduling of a previously…
Read the full analysis - Intimation of Investor MeetCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has issued an intimation regarding an upcoming analyst/investor meeting…
Read the full analysis - Intimation of Investor MeetCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has issued an intimation regarding an upcoming analyst/investor meet…
Read the full analysis - Intimation of Investor MeetCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has issued an intimation regarding an upcoming analyst/investor meet…
Read the full analysis - Intimation of Investor MeetCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has issued an intimation regarding an upcoming analyst/investor meet…
Read the full analysis - Newspaper Advertisement for publication for Financial ResultsCompany Updatelow impact
Cruxal's analysis: CARE Ratings Limited has published its financial results for the quarter ended June 30…
Read the full analysis - Intimation of Investor MeetCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has issued an intimation regarding a scheduled analyst/investor meet…
Read the full analysis - Press Release and Investor Presentation for the quarter ended June 30, 2026Company Updatehigh impact
Cruxal's analysis: CARE Ratings Limited delivered a strong performance for the quarter ended June 30, 2026…
Read the full analysis - Outcome of the meeting of the Board of Directors of CARE Ratings Limited held on August 7, 2026Board Meetinghigh impact
Cruxal's analysis: CARE Ratings Limited announced its unaudited financial results for the quarter ended June…
Read the full analysis - Allotment of 6,766 equity shares pursuant to exercise of ESOPCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has announced the allotment of 6,766 equity shares following the…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track CARE Ratings Ltd
Cruxal reads every CARE Ratings Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.